IL17A and metabolic dysfunction-associated steatohepatitis: Its activation promotes the differentiation of CD4+ T cells into the pro-inflammatory Th17 subtype and upregulates IL-17 production, thereby contributing to the occurrence of liver injury and fibrosis in NASH.29